Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland

Pediatric Blood and Cancer

Volumn 58, Issue 3, 2012, Pages 421-427

  Prasad, Pinki K ^a,b   Signorello, Lisa B ^b,c,d   Friedman, Debra L ^a,b   Boice, John D ^b,c,d   Pukkala, Eero ^e,f  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^e UNIVERSITY OF TAMPERE   (Finland)

^f FINNISH CANCER REGISTRY   (Finland)

Author keywords

Adolescent; Cancer; Cardiovascular diseases; Mortality; Pediatrics; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD CANCER; CONFIDENCE INTERVAL; FEMALE; FINLAND; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; STANDARDIZED MORTALITY RATIO;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; HUMANS; INFANT; INFANT, NEWBORN; MALE; MORTALITY; NEOPLASMS; RESPIRATORY TRACT DISEASES; SURVIVORS; YOUNG ADULT;

EID: 84855781583     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23296     Document Type: Article

References (46)

1. Horner MJ, Ries LAG, Krapcho M, et al. Seer cancer statistics review, 1975-2006. Bethesda, MD: National Cancer Institute; 2008.
2. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21: 3431-3439.
3. Anderson NE. Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol 2003; 16: 677-683.
4. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 2004; 42: 563-573.
5. Dama E, Pastore G, Mosso ML, et al. Late deaths among five-year survivors of childhood cancer. A population-based study in piedmont region, Italy. Haematologica 2006; 91: 1084-1091.
6. Hawkins MM, Kingston JE, Kinnier Wilson LM. Late deaths after treatment for childhood cancer. Arch Dis Child 1990; 65: 1356-1363.
7. Lawless SC, Verma P, Green DM, et al. Mortality experiences among 15+ year survivors of childhood and adolescent cancers. Pediatr Blood Cancer 2007; 48: 333-338.
8. MacArthur AC, Spinelli JJ, Rogers PC, et al. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer 2007; 48: 460-467.
9. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2008; 100: 1368-1379.
10. Moller TR, Garwicz S, Perfekt R, et al. Late mortality among five-year survivors of cancer in childhood and adolescence. Acta Oncol 2004; 43: 711-718.
11. Morris EB, Gajjar A, Okuma JO, et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 2007; 25: 1532-1538.
12. Nicholson HS, Fears TR, Byrne J. Death during adulthood in survivors of childhood and adolescent cancer. Cancer 1994; 73: 3094-3102.
13. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 3.0. Arcadia, CA: Children's Oncology Group; 2008.
14. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD; 1999.
15. Barakat LP, Alderfer MA, Kazak AE. Posttraumatic growth in adolescent survivors of cancer and their mothers and fathers. J Pediatr Psychol 2006; 31: 413-419.
16. Friedman DL, Meadows AT. Late effects of childhood cancer therapy. Pediatr Clin North Am 2002; 49: 1083-1106.
17. Green DM, Zevon MA, Hall B. Achievement of life goals by adult survivors of modern treatment for childhood cancer. Cancer 1991; 67: 206-213.
18. Hobbie WL, Hollen PJ. Pediatric nurse practitioners specializing with survivors of childhood cancer. J Pediatr Health Care 1993; 7: 24-30.
19. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 2003; 290: 1583-1592.
20. Kazak AE. Evidence-based interventions for survivors of childhood cancer and their families. J Pediatr Psychol 2005; 30: 29-39.
21. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 2001; 93: 618-629.
22. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004; 54: 208-236.
23. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
24. Mertens AC. Cause of mortality in 5-year survivors of childhood cancer. Pediatr Blood Cancer 2007; 48: 723-726.
25. Moller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the nordic countries. J Clin Oncol 2001; 19: 3173-3181.
26. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172.
27. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in finland. Acta Oncol 1994; 33: 365-369.
28. Statistics of Finland. Statistical yearbook of Finland 1999. Causes of death. Statistics Finland, Helsink; 1999.
29. Breslow NE, Day NE. Statistical methods in cancer research. IARC workshop 25-27 May 1983. IARC Sci Publ 1987; 82: 1-406.
30. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27: 2328-2338.
31. Nagarajan R, Kamruzzaman A, Ness KK, et al. Twenty years of follow-up of survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study. Cancer 2011; 117: 625-634.
32. Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst 2007; 99: 206-214.
33. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270: 1949-1955.
34. Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the cardiovascular disease task force of the Children's Oncology Group. Pediatrics 2008; 121: e387-e396.
35. Slama MS, Le Guludec D, Sebag C, et al. Complete atrioventricular block following mediastinal irradiation: A report of six cases. Pacing Clin Electrophysiol 1991; 14: 1112-1118.
36. Stewart JR, Fajardo LF. Radiation-induced heart disease: An update. Prog Cardiovasc Dis 1984; 27: 173-194.
37. Warda M, Khan A, Massumi A, et al. Radiation-induced valvular dysfunction. J Am Coll Cardiol 1983; 2: 180-185.
38. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339: b4606.
39. Aviles A, Neri N, Nambo JM, et al. Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy. Leuk Lymphoma 2005; 46: 1023-1028.
40. Kremer LC, van Dalen EC, Offringa M, et al. Frequency and risk factors of anthracycline-induced clinical heart failure in children: A systematic review. Ann Oncol 2002; 13: 503-512.
41. Kremer LC, van der Pal HJ, Offringa M, et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: A systematic review. Ann Oncol 2002; 13: 819-829.
42. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.
43. Ginsberg SJ, Comis RL. The pulmonary toxicity of antineoplastic agents. Semin Oncol 1982; 9: 34-51.
44. Kaplan E, Sklar C, Wilmott R, et al. Pulmonary function in children treated for rhabdomyosarcoma. Med Pediatr Oncol 1996; 27: 79-84.
45. O'Driscoll BR, Hasleton PS, Taylor PM, et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990; 323: 378-382.
46. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 2002; 95: 2431-2441.